Is it worth getting assessed for ADHD or autism as an adult?

What “worth it” depends on

There’s no single answer that fits every adult, because “worth it” measures several things at once. One is access: an assessment may be required for a specific service, ADHD prescription pathway, or documentation request. Another is clinical clarification: a qualified clinician can consider whether ADHD, autism, both, or another explanation best fits. A third is personal understanding: having language for a lifetime of patterns.

A diagnosis may help with all three, but none is guaranteed. Accommodation rules vary, clinical opinions can be incomplete or uncertain, and a diagnosis can bring relief, grief, doubt, or a mixture. Self-identification can support reflection, community, and practical strategies, but it cannot answer a differential-diagnosis question or replace assessment where a specific clinical pathway requires one.

So the useful question isn’t whether assessment is worth it in the abstract. It’s what outcome you need and how much a clinical opinion matters to you. The rest of this page lays out possible practical uses, process costs, and the experiences adults have reported after late diagnosis, so the trade-off is visible before you commit time or money to it.

Yes, you can be diagnosed as an adult

Adult diagnosis is standard, not a technicality. The current diagnostic manual, the DSM-5-TR, allows both conditions to be diagnosed in adulthood. For ADHD it asks that several symptoms were present before age 12, although it does not require a particular school record. For autism it asks that traits were present in the early developmental period, while allowing that they may have been masked or only became limiting once demands increased (American Psychiatric Association, 2022).

The numbers show how common late identification has become. In a 2023 U.S. survey, a weighted estimate of 15.5 million adults (6.0%) reported a current clinician diagnosis of ADHD, and 55.9% of that group reported being first diagnosed as adults (Staley et al., 2024). These were self-reported survey responses, not diagnoses verified from medical records. The two commercial panels had cumulative response rates of 3.8% and 4.0%, so nonresponse bias remains possible despite weighting.

For autism, exploratory projections using English primary-care records and assumed population-prevalence bounds estimated that 59% to 72% of autistic people in England may have been undiagnosed in 2018, with the gap concentrated among adults and especially older adults (O’Nions et al., 2023). This estimates diagnostic undercoverage in that population. It does not tell us whether any individual who suspects autism would meet diagnostic criteria.

What a formal diagnosis can open

A diagnosis can be useful for what it clarifies or makes easier. Four possible benefits come up most often.

Accommodation documentation. In the United States, autism and ADHD can qualify as disabilities under the Americans with Disabilities Act when they substantially limit a major life activity. When the disability or the need for an accommodation is not obvious, an employer may request reasonable documentation of the disability, functional limitation, and need. The EEOC, the US Equal Employment Opportunity Commission, says that request must be limited to relevant information and can be supported by various appropriate health or rehabilitation professionals; it is not automatically a demand for a full diagnostic report (U.S. Equal Employment Opportunity Commission).

Rules in higher education and testing vary. U.S. Justice Department guidance says supporting documentation, when required, should be reasonable and narrowly tailored, and may include more than a diagnostic evaluation (ADA.gov). In the UK, Acas, the public workplace advice service, says a worker does not need a diagnosis to be considered disabled under the Equality Act 2010 and should be offered support and reasonable adjustments with or without one (Acas). A formal report can still make some requests easier, and a particular university, insurer, program, or service may require one. Check the exact policy before paying for an assessment solely for paperwork.

ADHD treatment access. ADHD medication requires assessment by an appropriate clinician, and a diagnosis is normally part of that pathway. Autism assessment may inform care and support, but NICE, the body that sets clinical guidance for the NHS in England and Wales, recommends against using medication to manage the core features of autism in adults; clinicians may still use medication for a separate or co-occurring condition (NICE). Whether any specific treatment is appropriate is a question for a prescriber.

Documentation a particular setting accepts. A report can give employers, universities, insurers, or clinicians a shared reference. Whether that report is necessary or sufficient depends on the setting, so ask what evidence is accepted before arranging an assessment for that reason.

Clinical and personal understanding. Small studies describe this as meaningful for some adults, without establishing a guaranteed effect. A 2026 qualitative study interviewed 13 late-diagnosed autistic and ADHD adults and seven clinicians. Understanding, the burden of a label, and readiness were among its themes (French and Cassidy, 2026).

A qualitative study of 11 women diagnosed autistic after age 40 described relief and validation alongside difficult adjustment (Leedham et al., 2020). A cross-sectional online study of 151 UK adults found associations among time since diagnosis, autism-identity satisfaction, self-esteem, and wellbeing; it did not show that diagnosis caused those outcomes (Corden, Brewer and Cage, 2021).

Another study developed a scale from the reported impact of an autism diagnosis in 92 autistic adolescents and adults. Responses were generally positive for self-understanding but neutral for being understood by others and for service access (Arnold et al., 2020). A systematic review documented risks associated with undiagnosed ADHD and/or autism, but 14 of its 17 included studies concerned ADHD and the authors said the autism evidence was too limited for broad conclusions (French et al., 2023). Together, these studies document possible experiences and associations, not a guaranteed or causal improvement after diagnosis.

What it costs

The case against rushing into assessment is also evidence-based, and belongs here too.

Money and time. Assessment can be slow, expensive, or both. In a 2025 study, volunteer teams from 10 of Scotland’s 14 health boards supplied data on completed cases from 2021–22. Among 202 completed adult-service cases, the median time from referral to written outcome was 252 days. Cases that ultimately received ADHD without autism had a median wait of 63.4 weeks, compared with 38.6 weeks for cases that ultimately received autism without ADHD (Maciver et al., 2025). Those figures do not represent every referral, every service, or current waits.

Where public services are unavailable or backlogged, some adults consider private assessment paid out of pocket. Cost, timing, what the assessment includes, and whether another service will accept the resulting report all vary, so check those details before booking.

The risk of an incomplete answer. Assessments differ in scope and clinician experience. If you suspect both ADHD and autism, ask whether the provider assesses both and how they consider other possible explanations. An assessment focused on one question may not answer the other.

The label itself. The same 2026 study that documented benefits also identified the burden of a label, including stigma and other people’s responses (French and Cassidy, 2026). A diagnosis becomes part of relevant clinical records. Whether and where to disclose it outside care is a separate decision governed by the setting and applicable privacy rules.

Timing. Participants in that study also described readiness as decisive: the same diagnosis landed differently depending on whether the person was ready for it. There’s a version of “not yet” that’s a reasonable answer and not avoidance.

When self-identification is enough, and when it isn’t

This is a contested area, and flattening it would be a disservice.

On one side, self-identification is increasingly included in autism research. A 2024 scoping review of 13 online studies documented self-identification and reported barriers including cost, waits, and difficulty reaching assessment (Overton et al., 2024).

An online comparison found broadly similar autism-related identity, stigma, self-esteem, and quality-of-life patterns between self-reported diagnosed and self-diagnosed groups (McDonald, 2020). But the study explicitly could not determine whether the self-diagnosed participants were autistic. These studies support including self-identified people’s experiences in research; they do not measure the diagnostic accuracy of self-identification. For reflection, finding community, and trying low-risk day-to-day strategies, a formal label is not required.

On the other side, self-identification does not provide a clinical differential diagnosis and cannot substitute for the assessment required for ADHD medication. Some institutions and services also require documentation from a qualified professional, while others do not require a formal diagnosis. An editorial weighing the costs and benefits of a formal autism diagnosis frames the decision as a practical trade-off, not a contest over legitimacy (Fletcher-Watson, 2024).

The practical reading: identify the outcome you need, check whether that specific setting requires a diagnosis or another form of evidence, and decide how much a clinical opinion matters to you. Self-understanding and support strategies remain available while you decide.

How to decide

A short decision structure covers most situations.

First, list the outcomes you need. For workplace or academic accommodations, insurance coverage, or a particular service, ask what evidence is required. For ADHD medication, ask an appropriate clinician what assessment pathway applies where you live. If a needed next step requires a diagnosis, that weighs strongly in favour of assessment.

Second, weigh how much a clinician’s differential assessment matters to you. No assessment can promise perfect certainty, but a qualified clinician can consider ADHD, autism, co-occurring conditions, and other explanations in a way self-screening cannot.

Third, if neither applies strongly, self-identification may serve you for now, and you can revisit assessment if your needs change.

If you decide to pursue it, two things make the process more likely to return a full picture. Name both conditions at the start if you suspect both, since each can hide the other, and the practical mechanics of that are covered in our companion guide to getting an AuDHD diagnosis.

And before you commit, a structured self-reflection can help you decide whether a referral is worth seeking and clarify what to raise in a first appointment. The NeuroDiversion AuDHD self-reflection is built for that step. This decision has no universally right answer, which is why it stays yours to make and not one a page can make for you.